Hepatitis A: Clinical Trials

32 trials for Hepatitis A, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

23 completed, 4 unknown, 3 withdrawn, 1 active not recruiting. 32 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 432Completed 23, Unknown 4, Withdrawn 3, Active not recruiting 1, Not yet recruiting 1

Follow Hepatitis A: new trials by email Literature Review of Hepatitis A trials Research Report on Hepatitis A

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IV Study of Concomitant Administration of the sIPV and HepA
sIPV (booster dose at 18 months of age), HepA-L, HepA-I - Polio, Hepatitis A
Phase 4Not yet recruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences20002024-06-152024-06-14
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
HAVRIX - Cirrhosis, Hep A
Phase 4UnknownMahidol University502024-02-292024-03-19
Persistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.
Hepatitis A Vaccine - Hepatitis A
Phase 4UnknownBest Healthcare Inc.3002024-01-012023-12-28
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
2 doses of HAV, At least one dose of HAV - Hepatitis A, Immunodeficiency
Phase 4CompletedLiuZhou People's Hospital3922023-12-192025-12-31
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
Healive (hepatitis A vacine(human diploid cell), inactivated) - Hepatitis A
Phase 4Active not recruitingSinovac Biotech Co., Ltd10922023-10-242024-08-21
Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel
Havrix® - Hepatitis A
Phase 4WithdrawnGlaxoSmithKline2018-05-072018-03-02
Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients
Vaqta Injectable Product - Hepatitis A, Human Immunodeficiency Virus
Phase 4CompletedNational Taiwan University Hospital1532017-09-122023-01-26
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
Hepatitis A Vaccine - Hepatitis A
Phase 4UnknownChina National Biotec Group Company Limited3002017-07-262017-08-01
Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine
Measles vaccine, Hepatitis-A vaccine, Varicella vaccine - Measles, Varicella
Phase 4UnknownUniversity of Witwatersrand, South Africa2782017-04-102020-03-17
Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)
Blood sampling - Hepatitis B, Hepatitis A
Phase 4WithdrawnGlaxoSmithKline2015-05-012015-11-18
Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Blood sampling - Hepatitis A
Phase 4WithdrawnGlaxoSmithKline2015-05-012015-11-18
Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine
Inactivated Hepatitis A vaccine (HAV), Combined hepatitis A and hepatitis B vaccine (HABV) - Hepatitis A, Hepatitis B
Phase 4CompletedSinovac Biotech Co., Ltd3012014-05-012021-07-27
Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents
Avaxim 80U Pediatric: Inactivated Hepatitis A Virus - Hepatitis A, Hepatitis A Virus
Phase 4CompletedSanofi Pasteur, a Sanofi Company3552013-12-012015-10-01
The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Attenuated HAV Vaccine, H2 Strain, Attenuated HAV Vaccine, L-A-1 Strain, Inactivated HAV Vaccine, Lu8 Strain - Hepatitis A
Phase 4CompletedInstitute of Medical Biology, Chinese Academy of Medical Sciences350002013-09-012023-10-10
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Attenuated Hepatitis A Vaccine, H2 Strain, Inactivated Hepatitis A Vaccine, Lu8 Strain, Group A Meningococcal Polysaccharide vaccine - Hepatitis A
Phase 4CompletedJiangsu Province Centers for Disease Control and Prevention135002011-11-012015-11-10
Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients
Epaxal Berna (virosomal hepatitis A vaccine) - Inflammatory Bowel Disease, Crohn's Disease
Phase 4CompletedAsan Medical Center4932011-04-012013-03-19
Immunogenicity and Interchangeability of Two Inactivated Hepatitis A Vaccines
Healive+Healive, Healive+Havrix, Havrix+Havrix - Hepatitis A
Phase 4CompletedSinovac Biotech Co., Ltd3032010-04-012013-03-15
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
HAVpur Junior, Havrix 720 Junior - Hepatitis A
Phase 4CompletedCrucell Holland BV2512010-03-012013-12-17
Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult
Blood sampling, Engerix-B, Havrix - Hepatitis A, Hepatitis B
Phase 4CompletedGlaxoSmithKline502010-01-272019-02-01
Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult
Blood sampling, Engerix-B, Havrix - Hepatitis A, Hepatitis B
Phase 4CompletedGlaxoSmithKline442009-11-062018-09-04

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Hepatitis B (9)  ·  Hepatitis (3)  ·  Measles (3)  ·  Chickenpox (2)  ·  Mumps (2)  ·  Rubella (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Colitis, Ulcerative (1)  ·  Crohn Disease (1)  ·  Fibrosis (1)  ·  HIV Infections (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Inflammatory Bowel Diseases (1)  ·  Poliomyelitis (1)

Broader conditions

Digestive System Diseases (32)  ·  Enterovirus Infections (32)  ·  Hepatitis, Viral, Human (32)  ·  Infections (32)  ·  Liver Diseases (32)  ·  Picornaviridae Infections (32)  ·  RNA Virus Infections (32)  ·  Virus Diseases (32)  ·  Hepatitis (29)  ·  Blood-Borne Infections (11)  ·  Communicable Diseases (11)  ·  DNA Virus Infections (11)  ·  Hepadnaviridae Infections (9)  ·  Mononegavirales Infections (3)  ·  Morbillivirus Infections (3)

Interventions

Hepatitis A Vaccines (18)  ·  Blood Specimen Collection (5)  ·  Engerix-B (5)  ·  twinrix (4)  ·  Hepatitis B Vaccines (3)  ·  Aging (1)  ·  Chickenpox Vaccine (1)  ·  Freeze Drying (1)  ·  Measles Vaccine (1)  ·  Measles-Mumps-Rubella Vaccine (1)  ·  Vaccines (1)  ·  epaxal berna (1)  ·  measles, mumps, rubella, varicella vaccine (1)

Sponsors

GlaxoSmithKline (11)  ·  Sinovac Biotech Co., Ltd (5)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (2)  ·  Sanofi Pasteur, a Sanofi Company (2)  ·  Asan Medical Center (1)  ·  Best Healthcare Inc. (1)  ·  Centers for Disease Control and Prevention (1)  ·  China National Biotec Group Company Limited (1)  ·  Crucell Holland BV (1)  ·  Jiangsu Province Centers for Disease Control and Prevention (1)  ·  LiuZhou People's Hospital (1)  ·  Mahidol University (1)  ·  Merck Sharp & Dohme LLC (1)  ·  National Taiwan University Hospital (1)  ·  St. Joseph's Health Care London (1)

Countries

China (11)  ·  Belgium (9)  ·  Czechia (4)  ·  Germany (2)  ·  Canada (1)  ·  India (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Fubao Ma (2)  ·  Brian McMahon (1)  ·  Chien-Ching Hung (1)  ·  Christine H Lee, MD (1)  ·  Daljit Singh, MD (1)  ·  Fangjun Li, BS (1)  ·  Guodong Kang (1)  ·  Hemant Jain, MD (1)  ·  Hui Zhuang, Ph.D, MD (1)  ·  Jiawei Xu (1)  ·  Jingsi Yang (1)  ·  Jingsi Yang, PhD (1)

Results publications

PMID 32710245, PMID 21366801, PMID 24508042, PMID 26190091, PMID 11855555, PMID 16708058, PMID 17259872, PMID 20630640, PMID 22537990, PMID 24284413, PMID 25969561, PMID 27105563, PMID 28060048, PMID 28507927, PMID 28887164, PMID 30144521, PMID 31282539, PMID 32307279, PMID 33110280, PMID 33303216, PMID 34222044, PMID 37036404, PMID 38637212, PMID 40391688, PMID 7847285